<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35363605</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2150-5608</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Virulence</Title>
          <ISOAbbreviation>Virulence</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nepetin reduces virulence factors expression by targeting ClpP against MRSA-induced pneumonia infection.</ArticleTitle>
        <Pagination>
          <StartPage>578</StartPage>
          <EndPage>588</EndPage>
          <MedlinePgn>578-588</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2022.2051313</ELocationID>
        <Abstract>
          <AbstractText>The resistance of <i>Staphylococcus aureus</i> (<i>S. aureus</i>) to various antibiotics has increased dramatically due to the misuse of antibiotics, and thus the development of new anti-infective drugs with new targets is urgently needed to combat resistance. Caseinolytic peptidase P is a case in hydrolase that regulates the virulence level of <i>S. aureus</i>. Here, we found that nepetin, a small-molecule compound from traditional Chinese herbal flavonoids, effectively inhibits ClpP activity. Nepetin suppressed the virulence of <i>S. aureus</i> and effectively combated the lethal pneumonia caused by MRSA. The results of cellular thermal shift assay showed that nepetin could bind to ClpP and reduce the thermal stability of ClpP, and the <i>K</i><sub><i>D</i></sub> value of 602â€‰nM between them was determined using localized surface plasmon resonance. The binding mode of nepetin and ClpP was further investigated by molecular docking, and it was found that Ser-22 and Gln-47 of ClpP residues were found to be involved in the binding of nepetin to ClpP. In conclusion, we determined that nepetin is a ClpP inhibitor and an effective lead compound for the development of a virulence factor-based treatment for MRSA infection.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jing</LastName>
            <ForeName>Shisong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Xinran</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Science, Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Xiangri</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital to Changchun University of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xingye</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of integrated Chinese and Western medicine, College of rehabilitation, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Xiren</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Affiliated Hospital to Changchun University of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Xuerui</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Science, Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Science, Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Jiyu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Tiedong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>College of Animal Science, Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Bingmei</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Wu</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0002-1314-8018</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yicheng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Virulence</MedlineTA>
        <NlmUniqueID>101531386</NlmUniqueID>
        <ISSNLinking>2150-5594</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047309">Flavones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.92</RegistryNumber>
          <NameOfSubstance UI="C568646">ClpP protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.92</RegistryNumber>
          <NameOfSubstance UI="D049071">Endopeptidase Clp</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>I3O7LF3GED</RegistryNumber>
          <NameOfSubstance UI="C503624">eupafolin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D049071" MajorTopicYN="N">Endopeptidase Clp</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047309" MajorTopicYN="N">Flavones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055624" MajorTopicYN="Y">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">MRSA</Keyword>
        <Keyword MajorTopicYN="Y">anti-virulence</Keyword>
        <Keyword MajorTopicYN="Y">caseinolytic peptidase P</Keyword>
        <Keyword MajorTopicYN="Y">inhibitor</Keyword>
        <Keyword MajorTopicYN="Y">pneumonia</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>17</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35363605</ArticleId>
        <ArticleId IdType="pmc">PMC8986306</ArticleId>
        <ArticleId IdType="doi">10.1080/21505594.2022.2051313</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lowy FD.
Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520â€“532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9709046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Williams DJ, Arnold SR, et al. Community-Acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835â€“845. DOI:10.1056/NEJMoa1405870</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId>
            <ArticleId IdType="pmc">PMC4697461</ArticleId>
            <ArticleId IdType="pubmed">25714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistanceâ€”the need for global solutions. Lancet Infect Dis. 2013;13(12):1057â€“1098. DOI:10.1016/S1473-3099(13)70318-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(13)70318-9</ArticleId>
            <ArticleId IdType="pubmed">24252483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powers ME, Kim HK, Wang Y, et al. ADAM10 mediates vascular injury induced by Staphylococcus aureus Î±-hemolysin. J Infect Dis. 2012;206(3):352â€“356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3392186</ArticleId>
            <ArticleId IdType="pubmed">22474035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spaan AN, van Strijp JAG, Torres VJ. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. Nature Rev Microbiol. 2017;15(7):435â€“447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5621924</ArticleId>
            <ArticleId IdType="pubmed">28420883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salam AM, Quave CL. Targeting virulence in Staphylococcus aureus by chemical inhibition of the accessory gene regulator system in vivo. mSphere. 2018;3(1):3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5770542</ArticleId>
            <ArticleId IdType="pubmed">29359191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng AG, Kim HK, Burts ML, et al. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. Faseb J. 2009;23(10):3393â€“3404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2747682</ArticleId>
            <ArticleId IdType="pubmed">19525403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao P, Ho PL, Yan B, et al. Suppression of Staphylococcus aureus virulence by a small-molecule compound. Proc Natl Acad Sci U S a. 2018;115(31):8003â€“8008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6077739</ArticleId>
            <ArticleId IdType="pubmed">30012613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao J, Stewart GC. Regulatory elements of the Staphylococcus aureus protein A (SpA) promoter. J Bacteriol. 2004;186(12):3738â€“3748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC419937</ArticleId>
            <ArticleId IdType="pubmed">15175287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frees D, Qazi SN, Hill PJ, et al. Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol. 2003;48(6):1565â€“1578.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12791139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BÃ¶ttcher T, Sieber SA. Î²-Lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. J Am Chem Soc. 2008;130(44):14400â€“14401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18847196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michel A, Agerer F, Hauck CR, et al. Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J Bacteriol. 2006;188(16):5783â€“5796. DOI:10.1128/JB.00074-06</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00074-06</ArticleId>
            <ArticleId IdType="pmc">PMC1540084</ArticleId>
            <ArticleId IdType="pubmed">16885446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva LN, Zimmer KR, Macedo AJ, et al. Plant natural products targeting bacterial virulence factors. Chem Rev. 2016;116(16):9162â€“9236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27437994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thaler JS, Fidantsef AL, Duffey SS, et al. Trade-Offs in plant defense against pathogens and herbivores: a field demonstration of chemical elicitors of induced resistance. J Chem Ecol. 1999;25(7):1597â€“1609.</Citation>
        </Reference>
        <Reference>
          <Citation>Qiu J, Jiang Y, Xia L, et al. Subinhibitory concentrations of licochalcone a decrease alpha-toxin production in both methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Lett Appl Microbiol. 2010;50(2):223â€“229. DOI:10.1111/j.1472-765X.2009.02783.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1472-765X.2009.02783.x</ArticleId>
            <ArticleId IdType="pubmed">20025648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu J, Li H, Meng H, et al. Impact of luteolin on the production of alpha-toxin by Staphylococcus aureus. Lett Appl Microbiol. 2011;53(2):238â€“243. DOI:10.1111/j.1472-765X.2011.03098.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1472-765X.2011.03098.x</ArticleId>
            <ArticleId IdType="pubmed">21671964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BÃ¶ttcher T, Sieber SA. Î²-Lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angew Chem (Int Ed in English). 2008;47(24):4600â€“4603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18383487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hackl MW, Lakemeyer M, Dahmen M, et al. Phenyl esters are potent inhibitors of caseinolytic protease P and reveal a stereogenic switch for deoligomerization. J Am Chem Soc. 2015;137(26):8475â€“8483. DOI:10.1021/jacs.5b03084</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jacs.5b03084</ArticleId>
            <ArticleId IdType="pubmed">26083639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z, Shen ZH, Wu B, et al. Small molecule natural compound targets the NF-ÎºB signaling and ameliorates the development of osteoarthritis. J Cell Physiol. 2021;236(11):7298â€“7307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33870507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu K, Park C, Chen H, et al. Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling. Mol Carcinog. 2015;54(9):751â€“760. DOI:10.1002/mc.22139</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mc.22139</ArticleId>
            <ArticleId IdType="pmc">PMC4242796</ArticleId>
            <ArticleId IdType="pubmed">24700667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing S, Wang L, Wang T, et al. Myricetin protects mice against MRSA-related lethal pneumonia by targeting ClpP. Biochem Pharmacol. 2021;192:114753. DOI:10.1016/j.bcp.2021.114753</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2021.114753</ArticleId>
            <ArticleId IdType="pubmed">34474040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geiger SR, BÃ¶ttcher T, Sieber SA, et al. A conformational switch underlies ClpP protease function. Angewandte Chemie. 2011;50(25):5749â€“5752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21544912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc. 2007;2(9):2212â€“2221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17853878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455â€“461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3041641</ArticleId>
            <ArticleId IdType="pubmed">19499576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDocktools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785â€“2791. DOI:10.1002/jcc.21256</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcc.21256</ArticleId>
            <ArticleId IdType="pmc">PMC2760638</ArticleId>
            <ArticleId IdType="pubmed">19399780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niu X, Qiu J, Wang X, et al. Molecular insight into the inhibition mechanism of cyrtominetin to Î±-hemolysin by molecular dynamics simulation. Eur J Med Chem. 2013;62:320â€“328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23376250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mu D, Luan Y, Wang L, et al. The combination of salvianolic acid a with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus. Emerg Microbes Infect. 2020;9(1):169â€“179. DOI:10.1080/22221751.2020.1711817</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2020.1711817</ArticleId>
            <ArticleId IdType="pmc">PMC7006784</ArticleId>
            <ArticleId IdType="pubmed">31969071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigues T, Reker D, Schneider P, et al. Counting on natural products for drug design. Nat Chem. 2016;8(6):531â€“541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27219696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez Molina D, Jafari R, Ignatushchenko M, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341(6141):84â€“87. DOI:10.1126/science.1233606</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1233606</ArticleId>
            <ArticleId IdType="pubmed">23828940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1(9):727â€“730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12209152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang L, Li H, Jiang H, et al. An improved adaptive genetic algorithm for proteinâ€“ligand docking. J Comput Aided Mol Des. 2009;23(1):1â€“12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18777161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kebaier C, Chamberland RR, Allen IC, et al. Staphylococcus aureus Î±-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis. 2012;205(5):807â€“817. DOI:10.1093/infdis/jir846</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jir846</ArticleId>
            <ArticleId IdType="pmc">PMC3274379</ArticleId>
            <ArticleId IdType="pubmed">22279123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frees D, Gerth U, Ingmer H. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. Int J Med Microbiol. 2014;304(2):142â€“149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24457183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81â€“7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20597676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dickey SW, Cheung GYC, Otto M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017;16(7):457â€“471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28337021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun F, Zhou L, Zhao BC, et al. Targeting MgrA-mediated virulence regulation in Staphylococcus aureus. Chem Biol. 2011;18(8):1032â€“1041. DOI:10.1016/j.chembiol.2011.05.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chembiol.2011.05.014</ArticleId>
            <ArticleId IdType="pmc">PMC3163066</ArticleId>
            <ArticleId IdType="pubmed">21867918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thoendel M, Kavanaugh JS, Flack CE, et al. Peptide signaling in the staphylococci. Chem Rev. 2011;111(1):117â€“151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3086461</ArticleId>
            <ArticleId IdType="pubmed">21174435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seilie ES, Bubeck Wardenburg J. Staphylococcus aureus pore-forming toxins: the interface of pathogen and host complexity. Semin Cell Dev Biol. 2017;72:101â€“116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5823538</ArticleId>
            <ArticleId IdType="pubmed">28445785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran VG, Venkatasubramaniam A, Adhikari RP, et al. Efficacy of active immunization with attenuated Î±-hemolysin and panton-valentine leukocidin in a rabbit model of Staphylococcus aureus necrotizing pneumonia. J Infect Dis. 2020;221(2):267â€“275. DOI:10.1093/infdis/jiz437</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiz437</ArticleId>
            <ArticleId IdType="pmc">PMC6936001</ArticleId>
            <ArticleId IdType="pubmed">31504652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim G-L, Akoolo L, Parker D. The ClpXP protease contributes to Staphylococcus aureus pneumonia. J Infect Dis. 2020;222(8):1400â€“1404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7488198</ArticleId>
            <ArticleId IdType="pubmed">32386322</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
